These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bioequivalence studies of drugs prescribed mainly for women. McGilveray IJ J Popul Ther Clin Pharmacol; 2011; 18(3):e516-22. PubMed ID: 22113364 [TBL] [Abstract][Full Text] [Related]
3. Variation of drug kinetics in pregnancy. Pavek P; Ceckova M; Staud F Curr Drug Metab; 2009 Jun; 10(5):520-9. PubMed ID: 19689248 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring]. Panchaud A; Weisskopf E; Winterfeld U; Baud D; Guidi M; Eap CB; Csajka C; Widmer N Therapie; 2014; 69(3):223-34. PubMed ID: 25011648 [TBL] [Abstract][Full Text] [Related]
5. Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications. Koren G; Pariente G Pharm Res; 2018 Feb; 35(3):61. PubMed ID: 29435666 [TBL] [Abstract][Full Text] [Related]
6. Sex dependent pharmacokinetics and bioequivalence--time for a change. Koren G J Popul Ther Clin Pharmacol; 2013; 20(3):e358-61. PubMed ID: 24214491 [TBL] [Abstract][Full Text] [Related]
7. Mother and Child: Medication Use in Pregnancy and Lactation. Ito S Clin Pharmacol Ther; 2016 Jul; 100(1):8-11. PubMed ID: 27272612 [TBL] [Abstract][Full Text] [Related]
8. Use of Bayesian methods for multivariate bioequivalence measures. Molina de Souza R; Achcar JA; Martinez EZ J Biopharm Stat; 2009; 19(1):42-66. PubMed ID: 19127466 [TBL] [Abstract][Full Text] [Related]
10. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medications. DeVane CL NIDA Res Monogr; 1995; 149():116-29. PubMed ID: 8775838 [No Abstract] [Full Text] [Related]
14. Biowaiver: an alternative to in vivo pharmacokinetic bioequivalence studies. Mishra V; Gupta U; Jain NK Pharmazie; 2010 Mar; 65(3):155-61. PubMed ID: 20383933 [TBL] [Abstract][Full Text] [Related]
15. Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations. Ke AB; Greupink R; Abduljalil K CPT Pharmacometrics Syst Pharmacol; 2018 Feb; 7(2):103-110. PubMed ID: 29349870 [TBL] [Abstract][Full Text] [Related]
16. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I). Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Reeve E; Trenaman SC; Rockwood K; Hilmer SN Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):651-668. PubMed ID: 28460576 [TBL] [Abstract][Full Text] [Related]
18. Self-discontinuation of antiepileptic medication in pregnancy: detection by hair analysis. Williams J; Myson V; Steward S; Jones G; Wilson JF; Kerr MP; Smith PE Epilepsia; 2002 Aug; 43(8):824-31. PubMed ID: 12181000 [TBL] [Abstract][Full Text] [Related]
19. Fundamentals of Clinical Pharmacology With Application for Pregnant Women. Patil AS; Sheng J; Dotters-Katz SK; Schmoll MS; Onslow M; Pierson RC J Midwifery Womens Health; 2017 May; 62(3):298-307. PubMed ID: 28498553 [TBL] [Abstract][Full Text] [Related]
20. Considerations for metabolite pharmacokinetic data in bioavailability/bioequivalence assessments. Overview of the recent trends. Srinivas NR Arzneimittelforschung; 2009; 59(4):155-65. PubMed ID: 19517891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]